Patents Assigned to FAMAFARM S.R.L. (50%)
  • STABLE TOCOTRIENOL WITH IMMUNOMODULATING ACTION
    Publication number: 20230146726
    Abstract: The present patent application relates to a lyophilisation process of Annatto Bixa Orellana L. powder having a tocotrienol content >35% (w/w), comprising a pre-freezing step and a freeze-drying step, in which the Annatto powder resulting from the freeze-drying step (c) has a tocotrienol content >39% (w/w). The invention also relates to pharmaceutical compositions comprising lyophilised Annatto powder obtained with the process of the invention and therapeutic uses of such compositions, in particular to support cancer therapy.
    Type: Application
    Filed: March 16, 2021
    Publication date: May 11, 2023
    Applicants: FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI (50%), FAMAFARM S.R.L. (50%)
    Inventors: Cristina Ferraris, Francesca Ferri, Maria Teresa Armano